{'fraction_non_alphanumeric': 0.03270440251572327, 'fraction_numerical': 0.0037735849056603774, 'mean_word_length': 5.471544715447155, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Liposomes as Carriers of Anticancer Medicines

The aim of the work was the successful encapsulation of etoposide (ETO) and vinorelbine (VIN). Liposomes made from dipalmitylphosphatidylcholine (DPPC), liposomes containing both drugs (DPPC/ETO/VIN) and control liposomes DPPC/ETO and DPPC/VIN were prepared by the mREV method at 328 K. Liposome entrapped drugs were separated from free drugs by ultracentrifugation. The degree of encapsulation of drugs into liposome vesicles DPPC/ETO, DPPC/VIN and DPPC/ETO/VIN was estimated using UV spectrofluorescence after ultracentrifugation. The phase transition temperature was determined for all types of liposomes. The encapsulation efficiency, which is a measure of the percentage of the total compound entrapped within the liposome, is also determined.